277 related articles for article (PubMed ID: 7518644)
21. Interferon-new wonder drug or old laboratory curiosity?
Tannock GA
Med J Aust; 1981 Oct; 2(7):352-6. PubMed ID: 6170870
[No Abstract] [Full Text] [Related]
22. Clinical trials with interferon in Japan.
Imanishi J; Kishida T
Tex Rep Biol Med; 1981-1982; 41():647-52. PubMed ID: 6189229
[No Abstract] [Full Text] [Related]
23. Interferon (I): on the threshold of clinical application.
Marx JL
Science; 1979 Jun; 204(4398):1183-6. PubMed ID: 451564
[No Abstract] [Full Text] [Related]
24. [Nuclear pathway of interferons].
Silvennoinen O; Julkunen I; Alitalo K
Duodecim; 1993; 109(17):1447-9. PubMed ID: 7536657
[No Abstract] [Full Text] [Related]
25. Interferon: no magic bullet against cancer.
Sun M
Science; 1981 Apr; 212(4491):141-2. PubMed ID: 6163213
[No Abstract] [Full Text] [Related]
26. [Interferon. Uncertainties and prospects].
Rev Med Interna Neurol Psihiatr Neurochir Dermatovenerol Med Interna; 1981; 33(3):283-4. PubMed ID: 6171852
[No Abstract] [Full Text] [Related]
27. [Present interest and limits of human interferon in therapeutics].
Fauconnier B
Bull Acad Natl Med; 1981 Mar; 165(3):395-8. PubMed ID: 6173106
[No Abstract] [Full Text] [Related]
28. Interferons and interferon inducers: development of clinical usefulness and therapeutic promise.
Pollard RB
Drugs; 1982; 23(1-2):37-55. PubMed ID: 6173188
[No Abstract] [Full Text] [Related]
29. [The drug of first choice: interferon. Clinical pharmacological principles].
Del Vecchio S; Dianzani F
Minerva Gastroenterol Dietol; 1995 Mar; 41(1):81-7. PubMed ID: 7542487
[No Abstract] [Full Text] [Related]
30. Some thoughts on the clinical exploitation of interferon in infectious diseases.
Tyrrell DA
Interferon; 1982; 4():155-75. PubMed ID: 6195111
[No Abstract] [Full Text] [Related]
31. [Anti-viral and anti-neoplastic actions of interferon--with special reference to its clinical application].
Imanishi J
Nihon Rinsho; 1980 Sep; 38(9):3272-81. PubMed ID: 6166771
[No Abstract] [Full Text] [Related]
32. [Current status of the interferon system].
Berrocal F; Salvá JA
Med Clin (Barc); 1986 Oct; 87(12):515-8. PubMed ID: 2431235
[No Abstract] [Full Text] [Related]
33. [Monoclonal antibody therapy].
Schäffner G; Kabelitz D
Dtsch Med Wochenschr; 2001 Jul; 126(30):851-6. PubMed ID: 11512284
[No Abstract] [Full Text] [Related]
34. Interferons.
Balkwill FR
Lancet; 1989 May; 1(8646):1060-3. PubMed ID: 2469921
[No Abstract] [Full Text] [Related]
35. [Interferon as an antiviral, antineoplastic and immunomodulating agent].
Inglot AD
Postepy Hig Med Dosw; 1980; 34(2):89-105. PubMed ID: 6165980
[No Abstract] [Full Text] [Related]
36. [Anti-idiotypic antibodies in therapy: current status and prospects].
Perosa F; Dammacco F
Ric Clin Lab; 1989; 19 Suppl 2():69-85. PubMed ID: 2694309
[No Abstract] [Full Text] [Related]
37. [Natural and recombinant interferons].
Läer S
Med Monatsschr Pharm; 1999 Nov; 22(11):340-5. PubMed ID: 10596267
[No Abstract] [Full Text] [Related]
38. Interferon--the clinical experience.
van Helden PD
S Afr Med J; 1983 May; 63(20):773-5. PubMed ID: 6189199
[TBL] [Abstract][Full Text] [Related]
39. The dream for interferon.
Baron S
Hokkaido Igaku Zasshi; 1994 Nov; 69(6):1294-300. PubMed ID: 7535725
[No Abstract] [Full Text] [Related]
40. Genetic re-targeting of T lymphocyte specificity.
Bolhuis RL; Gratama JW
Gene Ther; 1998 Sep; 5(9):1153-5. PubMed ID: 9930314
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
